Best Healthcare Companies in Capital Region of Denmark, Denmark
The 154 best Healthcare companies in Capital Region of Denmark, Denmark in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Falck.
Ranked: Best Healthcare companies in Capital Region of Denmark
| # | Company | Disclosed funding | Last round | Employees | Founder | Tech stack | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|
| 1 | Falck Provider of emergency road ambulance services | $1.6B | 87 mo ago | 175 | Jakob Riis President and CEO | Optimizely Content ManagementApple iCloud MailMicrosoft 365+16 | — | 1 partnership · 1 expansion |
| 2 | Ferrosan Medical Devices Manufacturer of surgical haemostatic products and medical devices | $125M | 107 mo ago | 584 584 → 414 (-29%) · sector median -6% | Rasmus le Fevre CEO | WordPressMySQLPHP+17 | 235 patents Hemostatic medical devices and sprayable wound‑sealant compositions for surgical bleeding control | 6 job openings · 1 internship |
| 3 | Saniona Developer of drugs for CNS/Pain, autoimmune and metabolic diseases | $69M | 70 mo ago | 24 24 → 50 (+108%) · sector median -6% | — | WordPressApple iCloud MailMicrosoft 365+17 | 184 patents Kv7 potassium channel modulators and inhibitors for neurological therapeutic applications | — |
| 4 | Abacus Medicine Consulting services for market access, health economics and outcomes research | $58M | 71 mo ago | 1,052 1,052 → 1,072 (+2%) · sector median -6% | John Wagner Co-Founder | WordPressApple iCloud MailMicrosoft 365+14 | — | — |
| 5 | Freya CRO focused on clinical development services reproductive health | $38M | 19 mo ago | 7 | Johan Van Hylckama Vlieg CSO and co-founder | — | — | 2 awards |
| 6 | Medotech R&D company focused on manufacturing tooth grinding devices for multiple therapeutic areas | $30M | 204 mo ago | — | — | — | 21 patents Dental/ oral muscle monitoring and electrical stimulation devices for bruxism treatment | — |
| 7 | Teitur Trophics Provider of neurodegenerative therapeutics development services | $30M | 39 mo ago | 2 | Mathias Ollendorff Co-Founder | WordPressMySQLPHP+9 | 12 patents Peptide-based therapeutics targeting inner ear and mastoid disorders | 1 job opening · 2 awards |
| 8 | Octarine Producer of cannabinoid and psilocybin derivatives | $13M | 4 mo ago | 7 | Nick Milne Co-Founder and CSO | — | — | 1 job opening |
| 9 | NNIT Provider of digital transformation solutions, including custom application development, Microsoft D365 &… | $13M | 323 mo ago | 3,083 3,083 → 1,630 (-47%) · sector median -6% | — | VimeoTailwind CSSMicrosoft ASP.NET+11 | — | — |
| 10 | Enduro CDMO focused on manufacturing of microbial strains | $12M | 16 mo ago | 13 | Peter Rugbjerg Co-Founder & CEO | — | — | — |
| 11 | Chr. Olesen Distributor of ingredients to the livestock, food, and pharma industries | $11M | 128 mo ago | 54 | Mads Christian Olesen CEO | WordPress Block EditorwpBakeryWordPress+24 | — | 2 job openings |
| 12 | Chromaviso Provider of evidence-based lighting solutions for the healthcare sector | $6M | 55 mo ago | 29 | Anders Kryger Co-Founder & CEO | — | 16 patents Circadian lighting systems with programmable control and integrated graphical user interface displays. | 1 partnership |
| 13 | Notify Therapeutics Company focused on developing a novel hormone-free fertility treatment for women | $5M | 32 mo ago | 3 | Karin Hartmann Founder & CEO | — | — | — |
| 14 | Hemi Standalone headache clinic | $5M | 3 mo ago | — | Benedicte Dahl CEO | Webflow EcommerceWebflowSentry+22 | — | — |
| 15 | Mirrx Therapeutics Developer of microRNA-blocking oligonucleotides for cancer, cardiovascular, immunological and viral diseases | $4M | 129 mo ago | 11 | Hans Thorleif Møller Founder & CEO | — | 33 patents Antisense oligonucleotide design and delivery for cancer and RNA‑targeted therapies | — |
| 16 | InsuSense CRO focused on drug discovery and development for diabetes and other metabolic diseases | $2M | 128 mo ago | 1 | — | — | — | — |
| 17 | VenomAid Provider of point-of-care device for determination of snakebite | $2M | 28 mo ago | 11 | Cecilie Knudsen Co-Founder | — | — | — |
| 18 | Medicus Engineering Developer of devices for neuropathy, pressure soar and glucose level monitoring | $910K | 79 mo ago | 1 | Jesper Fleischer Co-Founder | — | 9 patents Physiological monitoring devices and closed-loop insulin infusion control systems | — |
| 19 | Biomonitor Provides CRO , patient monitoring and other biopharma development services | $877K | 158 mo ago | 1 | Arsalan Kharazmi Co-Founder & CEO | — | 7 patents Immunogenicity testing and patient suitability prediction for biopharmaceutical therapies | — |
| 20 | OSAA Manufacturer of medical devices | $838K | 65 mo ago | 2 | Jes Broeng Co-Founder | — | — | 2 expansions |
| 21 | Blue Cell Therapeutics Developer of stem cell therapies for the treatment of multiple diseases | $453K | 60 mo ago | 16 16 → 15 (-6%) · sector median -6% | Soren Sheikh CEO | — | — | — |
| 22 | Albumedix Offering albumin-based products and technologies that facilitate the development of biotherapeutics | $316K | 69 mo ago | 106 | — | — | 66 patents Engineered albumin proteins and conjugates for targeted drug delivery and therapeutic applications. | — |
| 23 | BioRepeller Bio-resistant polymer coating for Medical Devices | $180K | 156 mo ago | — | Kristian Kolind Co-Founder | — | — | — |
| 24 | Joninn Provider of medical device design & development and consulting services | $116K | 92 mo ago | — | Jacques Jonsman Founder | WordPressMySQLPHP+14 | — | — |
| 25 | BioPorto Diagnostics In vitro diagnostic tests and consumables | — | 13 mo ago | 39 39 → 44 (+13%) · sector median -6% | Peter Mørch Eriksen Group Chief Executive Officer | WordPressMySQLPHP+24 | 13 patents Clinical diagnostic assays targeting specific biomarker isoforms, notably renal injury markers | — |
| 26 | Zealand Pharma Developer of protein therapies for the treatment of diabetes and gastrointestinal diseases | — | 29 mo ago | 235 | Adam Steensberg CEO | Apple iCloud MailMicrosoft 365GSAP+15 | 1,274 patents Peptide therapeutics targeting IL‑23 receptor and gut‑hormone analogues (GLP‑2, glucagon) | 1 award |
| 27 | Ambu Company specializes in developing, producing, and marketing single-use medical devices | — | 38 mo ago | 4,917 4,917 → 2,486 (-49%) · sector median -6% | Britt Jensen Co-CEO | Cart FunctionalityDynamicwebApple iCloud Mail+14 | 971 patents Single-use airway and endoscopic devices with integrated imaging and noise-reduction technology | — |
Top 12 Healthcare companies in Capital Region of Denmark
#1
Series A · Copenhagen, Capital Region of Denmark · founded 2018 · 7 employees$12.8Mraised▾
Producer of cannabinoid and psilocybin derivatives
- Jan 2026Series A$5.9M
- Nov 2023Series A$4.6M
- Sep 2022Seed$2M
- Mar 2021Seed$2.2M
#2
Seed · Frederiksberg, Capital Region of Denmark · founded 2023$4.7Mraised▾
It is a wellness company that offers services and resources to support individuals on their journey to wellness. They provide information, forms, and rates for their offerings, and can be contacted via email or phone.
- Feb 2026Seed$4.7M
#3
Series A · Copenhagen, Capital Region of Denmark · founded 2023 · 7 employees$38Mraised▾
CRO focused on clinical development services reproductive health
- Nov 2024Series A$11.8M
- Dec 2023Series A$38M
#4
Series A · Copenhagen, Capital Region of Denmark · founded 2019 · 13 employees$12.4Mraised▾
CDMO focused on manufacturing of microbial strains
- Feb 2025Series A$12.4M
- Apr 2022Seed—
#5
Late Stage · Copenhagen, Capital Region of Denmark · founded 1906 · 175 employees$1.6Braised▾
Provider of emergency road ambulance services
#6
Series A · Aarhus, Capital Region of Denmark · founded 2020 · 2 employees$30Mraised▾
Provider of neurodegenerative therapeutics development services
- Mar 2023Series A$30M
- 2020Seed—
#7
Public · Ballerup, Capital Region of Denmark · founded 2011 · 24 employees$69Mraised▾
Saniona is focused on developing drugs for diseases of the central nervous system, autoimmune diseases, metabolic diseases, and treatment of pain. Its drug pipeline includes Tesofensine, a triple monoamine reuptake inhibitor for Obesity (Phase 2); Tesomet, a combination of tesofensine and metoprolol for Type 2 diabetes (Phase 2) and Prader-Willi syndrome (Phase 1); NS2359, a triple monoamine reuptake inhibitor for cocaine addiction (Phase 2); AN363 (GABAA α2/α3 program) for neuropathic pain (Preclinical). The company also has developed drugs for Ataxia, Parkinson's, and IBD disease.
- Aug 2020Post IPO$65M
- May 2017Post IPO$4M
#8
Acquired · Soborg, Capital Region of Denmark · founded 1920 · 584 employees$125.3Mraised▾
Manufacturer of surgical haemostatic products and medical devices. It develops and manufactures products for haemostasis and biopsy procedures. These include absorbable gelatin sponges, haemostatic matrices, and a handheld breast biopsy device. The company provides a full range of services from initial product conception and development through to manufacturing. Products are CE marked and FDA approved, adhering to GMP regulations.
#9
Series A · Copenhagen, Capital Region of Denmark · founded 2021 · 3 employees$5.3Mraised▾
It is a biotech company focused on developing a novel hormone-free fertility treatment for women with diminished ovarian reserve. They target the initial ovarian follicle development in the hormone-independent phase to address infertility. The company has received funding from Lundbeckfonden BioCapital and +ND Capital.
- Sep 2023Series A$5.3M
#10
Series A · Copenhagen, Capital Region of Denmark · founded 2004 · 1052 employees$57.6Mraised▾
Abacus Medicine offers consulting services for market access, health economics, and outcomes research. They provide services for strategic business development and support, quality and compliance, cGMP, clinical monitoring, health economic evaluations, and pharmaceutical sales.
#11
Seed · Virum, Capital Region of Denmark · founded 2017 · 11 employees$1.8Mraised▾
VenomAid provides diagnostic solution to the snakebite crisis. The product is a point-of-care device that provides a diagnostic result within minutes along with identifying the type of snake. The device works when loading blood is transferred directly from the site of the bite onto the device.
- Jan 2024Seed$1.8M
#12
Late Stage · Aarhus, Capital Region of Denmark · founded 2004$30Mraised▾
R&D company focused on manufacturing tooth grinding devices for multiple therapeutic areas
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Healthcare coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising